LENZ
LENZ Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.07
−1.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.58x
- Price / sales
- 5.95x
- Price / cash flow
- -1.12x
Enterprise value
- Enterprise value
- -$92.0M
- EV / sales
- -4.28x
- EV / EBITDA
- 0.73x
- EV / EBIT
- 0.68x
- Market cap
- $127.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026